Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study group.
暂无分享,去创建一个
G. Salles | R. Bouabdallah | J. Jais | A. Stamatoullas | O. Casasnovas | C. Gisselbrecht | C. Sebban | M. André | F. Morschhauser | P. Brice | D. Cazals‐Hatem | L. Voillat | K. Bouabdallah | M. Diviné | C. Fermé | M. Diviné